• Profile
Close

Evaluation of biomarkers in myoma patients: A prospective study investigating the role of LDH, CA 125, and IGF-1 after uterus-preserving surgical therapy

Gynecologic and Obstetric Investigation Feb 18, 2021

Jacob M, Richter R, Sehouli J, et al. - The prevalent diagnostic standards for myomas include sonography and clinical examination, and there have been no biomarkers established yet. Researchers here examined if lactate dehydrogenase (LDH), CA 125, and/or insulin-like growth factor (IGF-1) declined following the surgical removal of myomas. In addition, they tested the appropriateness of these parameters as potential biomarkers for the presence or recurrence of a myoma. In 83 patients (age 18–50) with a verified diagnosis of myomas and surgical therapy, they determined the blood levels of LDH, CA 125, and IGF-1 at 3 different timepoints: preoperative (T0), 2 days postoperative (T1), and 6 months postoperative (T2). A significant decline in both LDH and IGF-1 was observed in the immediate postoperative days in women with myomas after undergoing uterus-preserving surgeries. They observed correlation of postoperative concentration of IGF-1 with the evidence of new myomas and suggested its potential utility for further monitoring. Based on findings, they conclude that LDH and IGF-1 are influenced by myomas and could possibly be suitable as biomarkers.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay